Clinicians do not have time for your interface.
Health software is used by people mid-shift, under pressure, with a patient waiting. Software that costs them thirty seconds per record gets worked around, and a workaround in a clinical setting is a risk.
Patient data has rules, and they vary by border
Where data lives, who may see it, how long it is kept and what has to be logged are legal questions before they are technical ones, and the answers change between jurisdictions. Data residency and access control belong in the architecture from the first week, because moving them later means moving everything.
The workflow is the safety feature
Clinical software is used in interruption. A flow that assumes an uninterrupted user, or that buries a critical field three screens deep, produces errors that are recorded as human error. Designing for the actual conditions of a shift is a patient safety decision, not a usability preference.
Interoperability is the whole job
A health product almost never owns its data. Records live in an existing system, a lab platform, a national registry. Standards like HL7 and FHIR exist because of this, and a product that treats integration as a later phase has deferred the hardest part of the build.
AI here has a different burden of proof
A model that suggests a diagnosis is making a claim somebody clinically accountable has to stand behind. That demands traceable inputs, a visible confidence position, and a design that keeps the clinician deciding. AI that hides its reasoning is unusable in this setting regardless of accuracy.
Compliance shapes the architecture, not the launch checklist
Residency, access control and audit logging are decided at the start. We have delivered for Fortune 500 accounts under clinical compliance and EU data residency requirements, and the lesson from that work is that these are architectural constraints, not paperwork.
Designed against a real shift
Flows are built for the interrupted, time-pressured case rather than the demo case, because the demo case is not where the errors happen.
AI that shows its working
Retrieval that cites its source, confidence a clinician can see, and a human decision point that the system never routes around.
Our strongest ground of the five. TKRX is an AI platform for healthcare operations, live and in the portfolio. The founder took third prize at the Huawei Developer Competition 2025 Northern Africa Finals for an AI healthcare platform, against 389 teams and more than 1,400 developers across 10 countries. Add delivery for Fortune 500 accounts under clinical compliance and EU data residency, and this is the vertical where our record is deepest.
Questions we getCan you work within our data residency requirements?
Yes, and we treat it as an architecture question rather than a hosting setting. We have delivered under EU data residency requirements for Fortune 500 accounts. The requirement gets established before the build, because retrofitting residency means moving the system.
Do you integrate with existing hospital or clinic systems?
Yes, and it is usually the largest part of the work. Health products rarely own their records, so the integration surface, HL7 and FHIR included where relevant, gets scoped in discovery rather than discovered mid-build.
How do you handle AI in a clinical product?
As assistance with visible reasoning, never as a decision the system makes on its own. Retrieval cites its source, confidence is shown rather than hidden, and a clinically accountable human stays in the loop by design.
Discover how partnering with Nemo can drive your success and prepare you for what's next.